FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3024011000001105: Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 22-Jun 2016. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    26098301000001118 Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    38140101000001110 Relifex 500mg/5ml oral suspension (Meda Pharmaceuticals Ltd) 300 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Is a Nabumetone 500mg/5ml oral suspension sugar free 300 ml false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Is pack of Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Has active ingredient Nabumetone false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Legal category Prescription only medicine - legal category (qualifier value) false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Has AMP Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Has specific active ingredient Nabumetone false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Has dispensed dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Is a Actual medicinal product pack false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
    Relifex 500mg/5ml suspension (Meda Pharmaceuticals Limited) 300 ml VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start